incidence of clinical cancer are available, but once more problems of educating the public present themselves. Screening programmes on a national scale to detect early or preclinical cancer are fraught with difficulties. Out of a total of some 15 million women in this country between the ages of 15 and 65 fewer than 2 million submitted themselves for cervical smears last year. Further, half of the tests that were carried out were performed on women under the age of 35, though the age of maximum risk is over the age of 35. The success of screening programmes depends on the facilities available and the efficiency and accuracy of any screening procedures, but of equal importance is the motivation of the patients at risk to come forward for examination.
Cancer of the body of the uterus is becoming more frequent. Why is this ? It is a disease of older women, and women are living longer. But this is not the only factor. There is a relationship between this disease and obesity and diabetes, both of which are also increasing in an affluent society. The exact relationship between this disease and oestrogens is not fully understood, but that there is such a relationship seems highly probable. Future research may show the part which progestogens may play, not only in the treatment of benign hyperplasia but by its successful treatment they may have a role in the future prevention of malignant change. We therefore have a situation in which improvement in the standards of living and better education may be reducing the incidence of one disease while causing an increase in the incidence of another.
Conclusion
The whole of our medical service has been geared towards curative medicine, and the whole of medical education is designed to produce a doctor more capable of treating disease than in preventing it. Our profession is frequently criticized for this attitude. But does not the relative indifference of the public to preventive measures reflect the same attitude, and is it not true that it is vastly easier to obtain finance whether from public or private sources to develop treatment and research rather than to publicize methods of prevention? Cancer research is oversubscribed, cancer education almost entirely unfunded. The (Mookerjee, Gault, and Dossetor, 1969) ; 24-hour urinary osmolarity (Chisholm, Papadimitriou, Kukatilake, and Shackman, 1969) ; creatinine clearance (Rapoport and Husdan, 1968) ; Hippuran 131I clearance (Kountz, Luab, and Cohn, 1965; Awad, Bennett, and Martin, 1968) ; graft biopsy (Kincaid-Smith, 1967; Kincaid-Smith, Morris, Saker, Ting, and Marshall, 1968; Millard, Herbertson, and Evans, 1970) ; ultrasonic renal flow measurements (Sampson, 1969) ; fibrinogen 1311 uptake (Salaman, 1970) ; urinary lymphocyte count (Hume, Magee, and Kauffman, 1963) ; and thermography (Birsner, Gershon-Cohen, and Gainey, 1971) . The disadvantage of these tests is that in effect they can detect only renal damage.
Other tests examine lymphocyte function as a criterion of the cellular immunity responsible for allograft rejection (Russel and Monaco, 1964) . These include: lymphocyte transformation (Tennenbaum, St. Pierre, and Cerilli, 1968) ; leucocyte migration (Smith, et al., 1969) ; and RNA synthesis (Parker, 1969; Parker, Ellis, Cameron, and Ogg, 1970; Parker and Mowbray, 1971) . These tests take 12-24 hours to produce results, during which time irrecoverable renal damage may occur. They do, on the other hand, measure the activity of the lymphocyte and thus may give warning of impending rejection episodes.
Bach and his colleagues first showed in 1968 that the formation of rosettes was a sensitive in-vitro method of assessing the potency of antilymphocyte sera (Bach and Antoine, 1968; Bach, Dardenne, and Antoine, 1968 Balner, 1970; Bach and Dormont, 1971) . The rosette test performed with the use of mouse cells from mice immunized with sheep red cells (Bach, Dardenne, and Fournier, 1969a) proved as sensitive for the immunosuppressive activity of cemical immunosuppressive agents such as azathioprine. As an index of immunosuppression the inhibition of spontaneous rosette formation has also been studied in dogs and man with renal allografts treated with A.L.G. Brain, Gordon, and Willetts, 1970; Bach, Dormont, Dardenne, and Balner, 1969b; Salerni et al., 1970) .
The mechanism of spontaneous rosette formation is still obscure. It has been suggested that the sheep red blood cells have an antigenic site (or sites) on the plasma membrane which causes them to adhere to the lymphocytes. Biozzi et al. (1966) and Bach et al. (1969a) thought that the lymphocytes involved were those producing antibody with the antibody remaining on the cell membrane. Storb and Weiser (1966) referred to this as immunocytoadherence. Bach and Dormont (1971) put evidence forward that the central cell appeared to be a thymusdependent antigen-sensitive cell. suggested that the active peripheral lymphocyte produces a substance which remains attached to its surface and by its molecular configuration can at the same time bind to the antigens on the sheep red cell membrane. Immunosuppressive drugs such as azathioprine and prednisone probably inhibit the formation of this substance. The action of A.L.G. would be to "coat" the lymphocytes involved, preventing this adherence.
We have used in man a test based on the inhibition of spontaneous rosette formation by peripheral blood cells of the lymphocyte series. It seemed possible that cells already subjected to immunosuppressive drugs in vivo may be more susceptible to the inhibitory action of an A.L.G. of known standard potency. Their susceptibility could be tested by measuring the concentration of the standard A.L.G. required to inhibit their spontaneous rosette formation when incubated with sheep red cells. This might give an index of how suppressed the cell-mediated immune responses of the donor of the lymphocytes might be, and hence whether rejection of an allograft might be expected or might even be taking place.
The data presented in this paper are consistent with both these hypotheses, and we suggest that this type of rosette inhibition test forms a theoretically interesting and clinically useful system.
Method of Preparing Rosettes
The method was based on that described by Bach and Antoine (1968) . The lymphocytes were obtained by filtering 5-7 ml of freshly-drawn citrated blood (10% trisodium citrate, 1 ml to 9 ml of blood) through a column of nylon wool (Rogier Bellon, Paris) and sedimented by adding 5% dextran (Poviet Production, N.V., Amsterdam) to a final concentration of 10/. The mixture was allowed to stand for 45 minutes at 37°C before being centrifuged at an angle of 45 degrees for 10 minutes at 1,000 r.p.m. (160 g) and the supernatant discarded.
The residue, which contained the cells, was washed twice in isotonic saline, resuspended in 1 ml of saline, and shaken gently with 3 ml of distilled water for 20 seconds to haemolyse the red cells. The 24 hours of a clinical rejection episode-the episodes were diagnosed on the usual criteria of increasing proteinuria, blood urea, and serum creatinine, with a fall in urinary output and creatinine clearance.
Results
The results are shown in Fig. 4 . In the 25 normal subjects (group 1) the range of M.I.C.s was 1/16,000 to 1/32,000, while in 32 tests carried out on 23 patients with long-term successful renal allografts (group 4) the average titre was 1/112,000 (range 1/96,000 to 1/218,000). Results from 23 patients with renal allografts in the first six months (group 3) showed a wide range of M.I.C. titres. The majority had titres at 1/64,000 or above (average M.I.C. 1/96,000). The eight results at 1/16,000-1/32,000 were from three patients. One developed a urinary fistula five days after receiving an "identical" matched allograft (Batchelor and Bristol plates). Clinically no rejection was observed. This may represent the relatively small stimulation to the immune system by a well-matched allograft at this early stage, though it is of note that his renal function did not improve until after the M.L.C. titre was greater than 1/64,000. The other two patients had improving renal function at the time of the test but within one week and without further rosette tests had clinical rejection.
The 21 results recorded in group 5 were from 19 patients showing clinical signs of rejection. The tests were carried out on samples of blood taken before antirejection treatment was started. In only two episodes did a second sample, taken at 12 hours after the beginning of the treatment, show a lack of inhibition. In both these cases the rejection was not reversed and necessitated the patient returning to the dialysis programme. BRITISH MEDICAL JOURNAL 31 juLy 1971 In none of the rejection episodes that were successfully treated was the dilution of A.L.G. less than 1/64,000 -12 hours after starting the treatment. It is interesting to note that though most of the M.I.C.s were in the normal range a few showed dilution less than this, suggesting that these lymphocytes were even harder to inhibit or suppress than those in patients on routine immunosuppression.
In the 15 patients on regular haemodialysis (group 2) the results showed that most had dilution titres greater than normal though less than those on routine immunosuppression (groups 3 and 4). Discussion Bach, Dardenne, and Fournier (1969a) found that in only 30-40% of their normal subjects could they obtain spontaneous rosette formation. In our experience we have not yet found a person who does not form some rosettes spontaneously. This has been confirmed by B. Mosedale (personal communication, 1971 ). showed that if the lymphocytes were washed thoroughly the postulated surface substance might be removed from the cells. This may be the reason for failure to form rosettes in some instances.
The identification and specificity of the rosette-forming cells have been discussed by Bach et al. (1968) , , and Bach and Dormont (1971) . Bach and Dormont (1971) reviewed the convincing evidence that the cells involved in their mouse system were dreived from T lymphocytes. In man much less data are available, but the spontaneous rosette rate (rosette/ 1,000 lymphocytic cells) is much higher than in the mouse. Our own preparations stained with methylene blue show two types of cells which can easily be distinguished-small lymphocytes and larger cells with diffuse foamy nuclei, which we term "macrophages" (Fig. 1) . Electron microscopical studies of rosette-forming cells in the mouse (Reyes and Bach, 1970) suggest that at least these two types of cell are involved in forming rosettes. In man it is possible that other cell types may be involved, and the method of preparing the cells from the peripheral blood will influence this.
If would be of great interest to investigate the nature of the rosette-forming cells in human peripheral blood. Nevertheless, our ignorance of the exact type or types of cell involved and of the specificity and significance of them does not detract from the practical value of the test at present described.
In those patients on haemodialysis the results showed at least partial inhibition of spontaneous rosette formation in most cases. There is other evidence of impairment of cellular immunity associated with uraemia. Prolonged skin graft survival has been reported by Smiddy, Burwell, and Parsons (1961) and by Dammin, Cough, and Murray (1957) . Uraemic patients also had fewer positive intradermal skin tests of the delayed hypersensitivity type to various antigens than their related controls, according to Kirkpatrick, Wilson, and Talmage (1964) . The response of lymphocytes to phytohaemagglutinin was reported as normal by Kasakura and Lowenstein (1967) and abnormal by Elves, Israels, and Collinge (1966) . Folb (1970) postulate that all patients with dilution titres less than 1/64,000 were capable of rejection. Now the prednisone dosage can be reduced quickly, but even in the absence of clinical or laboratory criteria consecutive test results between 1/64,000 and 1/50,000 are treated by increasing the prednisone dosage by 20-30 mg daily until the M.l.C. is greater than 1/64,000. The immunosuppressive therapy can then after a few days be reduced slowly, the rosette inhibition being carefully watched. Test results less than 1/50,000 in the absence of clinical signs are treated with 100 mg of prednisone for three days, thereafter reducing the dosage. Full conventional antirejection treatment is given if clinical signs are present. Care has to be taken in assessing single results. Technical errors can to a large extent be eliminated by using the percentage inhibition results from a true sigmoid curve. Where there have been wide changes in immunosuppressive therapy or in the M.I.C. titres over a short period to time the test should be repeated. Falling M.I.C. titres with constant immunosuppression, even when above 1/64,000, should also be watched carefully.
The plasma creatinine, creatinine clearance, M.I.C. titres, and the immunosuppressive therapy in a girl who received a renal allograft six months previously are shown in Fig. 5 . It shows how the prednisone dosage can be reduced to low levels rapidly and safely and still maintain improving renal function. It also shows that the test can be used to reduce the immunosuppressive therapy safely in the anuric period without the fear that a rejection episode is being missed in the absence of the usual clinical criteria. Similar clinical criteria and two rejection episodes at about the 40th and 115th days after transplantation are shown in Fig. 6 The infusion rates were adjusted so that contractions occurred optimally every two to three minutes and lasted 40-50 seconds, and the infusion was maintained until delivery in each instance. Uterine contractions and fetal heart recordings were monitored continuously throughout labour with a Hewlett Packard cardiotocograph. Baseline recordings were obtained for at least 15 minutes before the start of infusion. During the induction of labour the membranes were ruptured artificially only in those cases of suspected fetal distress, as determined by fetal heart variations of more than 30 minutes' duration. In these subjects fetal blood samples were taken and they were subsequently eliminated from the final analysis. This was made on 30 patients, 15 in each group.
The essential criterion chosen to indicate successful induction was dilatation of the cervix. Since both primigravid and multigravid patients were studied it was decided to regard an increase in dilatation over that present before the onset of infusion as evidence of success rather than cervical dilatation of a certain arbitrary degree. Failure was considered to have occurred if there was no change over a 12-hour period. In this event the infusion was stopped, the patient was allowed to rest for the night, and other plans were made to effect delivery the next day. If progress had occurred infuLsions were kept running until delivery, maintaining contractions at the optimum rate and duration. Vaginal examinations were performed every four hours by one observer in each case. The degree of cervical dilatation was noted on each occasion though consideration was not given to changes in the length of the cervical canal.
Before the infusion was started each subject had an epidural catheter inserted. Bupivacaine 0 5% was later given at intervals as required, ensuring a standard method of analgesia and facilitating accurate recording of contractions and fetal heart rate by the external cardiotocograph. The times of alteration in the infusion rate were recorded, ensuring knowledge of the total quantity of each agent used. The times of onset of spontaneous membrane rupture and full dilatation were noted, as was the presence of any maternal cardiovascular or gastrointestinal side effects. Fetal well-being was assessed by Apgar scores taken at one and five minutes. At the conclusion of the study an attempt was made to correlate the Apgar score and the occurrence of type 2 decelerations in fetal heart rate recorded on the cardiotocograph with the agent used.
TITRATION SCHEDULES
Oxytocin.-The regimen used was that described by Turnbull and Anderson (1968) . The infusion was started at 1 mU/min, the rate being doubled every 10 minutes until contractions
